Page 1457 - Problem-Based Feline Medicine

1450 INDEX

Mammary gland tumors, 1068, Maternal neglect, 1135–1137 Meglumine antimonate, 1382
1076–1077 clinical signs, 1136 Meibomian gland adenocarcinoma,
Mandibular fracture, 603, 610 diagnosis, 1136 1209, 1225–1226, 1229
Mange, notoedric see Notoedres cati differential diagnosis, 1136 Meibomian gland inflammation,
(notoedric mange) fading kitten/neonate, 1127, 1225–1226
Mannitol, 1380 1135–1137 Meibomitis, 1318, 1324–1325
acute renal failure and, 282 inadequate milk supply, 1135, 1136 Melanoma, 1079, 1097
brain edema, 818 pathogenesis, 1135–1136 iris, 1268, 1298
ciguatoxin, 973 prevention, 1137 non-healing wounds, 1082, 1097
feline ischemic encephalopathy, 805 prognosis, 1137 skin lumps/bumps, 1068, 1079
head trauma, 824 treatment, 1136–1137 Melena, 493
Mannosidosis, 925, 935–936 Maxillary fracture, 603, 610 Meloxicam, 1382
Manx cat Mebendazole, 1381 Melphan, 1382
corneal dystrophy, 1255, 1264–1265 Meclizine, 1381 Melting ulcer see Keratomalacia
sacrococcygeal dysgenesis, 919, Medetomidine, 1381 (melting ulcer)
920, 921 Medial amygdaloid nucleus, 994 Menace response loss, 1188
spina bifida, 990 Mediastinal masses, 56–57, 85 Menaquinone see Vitamin K
2
stromal dystrophy, 1234, 1252 coughing, 91, 107 (menaquinone)
Marbofloxacin, 1380 dyspnea/tachypnea, 49, 56–57 Meningioma, 218, 227, 810, 825
Marijuana poisoning, 284 hydrothorax, 72, 85 intracranial, 925
Marine benthic dinoflagellate, 972 Mediastinal neoplasia, 78, 614, 628 tremor/twitching, coarse
Marine fish Medical dissolution, urolithiasis, 186 (intentional), 858
ciguatoxin, 971–973 Medroxyprogesterone acetate, 1381 urination, inappropriate, 227
tetrodotoxin, 945 Medullary osmotic gradient Meningitis, 297, 632, 659
Marine (fish) oils, hyperlipidemia, 574, compromise, 234 Meningoencephalitis
969 Megacolon, 445, 465, 783–786 differential diagnosis, 1340
Masson’s trichrome stain, 1101 abdominal distention/fluid, 445, 465 feline infectious peritonitis and,
Mast cell activation, 175 clinical signs, 781 911
Mast cell stabilizers, 95 definition, 783 non-suppurative, 367, 379–380, 797,
Mast cell tumor, 394, 409, 1046, 1050, idiopathic, 783–786 803–804
1074–1075, 1092–1093 Megaesophagus Mepiridine, 1382
clinical signs, 1074, 1092–1093 clinical signs, 593 Mepivacaine, 1382
diagnosis, 1075, 1093 dysautonomia, 661 6-mercaptopurine, 1382
differential diagnosis, 1075 fading kitten/neonate, 1139 Meropenem, 1382
eyelid, 1318, 1321–1322 hypoadrenocorticism and, 754 Mesenchymal cells, 1071
intestinal see Intestinal mast cell regurgitation, 613, 614 Mesenteric lymphadenopathy,
tumor secondary causes, 621 alimentary lymphosarcoma, 742
mastocytic/histiocytic, 1074–1075 Megakaryocytic hypoplasia, 482, Mesna, 1382
non-healing wounds, 1082, 495–497 Mesodermal origin malformations, 919
1092–1093 clinical signs, 496, 506–507 Mesothelioma, 57, 85, 107
pathogenesis, 1074 diagnosis, 496 Metabolic acidosis, fluid therapy, 558
prognosis, 1075 differential diagnosis, 496–497 Metabolic alkalosis, fluid therapy, 558
pruritus, 1050 hemorrhage, 495–497 Metabolic diseases see specific
skin lumps/bumps, 1068, pathogenesis, 495–496 diseases/disorders
1074–1075 prognosis, 497 Metabolic encephalopathy, 822,
splenic, 461 treatment, 497 830–832
third eyelid, 1338 Megestrol acetate, 1343, 1348, Metabolic epidermal necrosis (MEN),
treatment, 1075 1381–1382 1082, 1099–1100
visceral, 444, 461–462 administration, 254 Metaldehyde poisoning/toxicity, 284,
Mastectomy, 1076–1077 eosinophilic granuloma complex, 813
Mastication (lockjaw) tetanus, 1339 587 Metamucil, 1382
Mastitis, 1135 non-obstructed idiopathic lower Metaproterenol sulfate, 1382
Maternal aggression, 994, 1006–1007 urinary tract disease, 178 Metaraminol, 1382